Insulin-like growth factor-1 sustains stem cell mediated renal repair
- PMID: 17942965
- DOI: 10.1681/ASN.2006121318
Insulin-like growth factor-1 sustains stem cell mediated renal repair
Abstract
In mice with cisplatin-induced acute kidney injury, administration of bone marrow-derived mesenchymal stem cells (MSC) restores renal tubular structure and improves renal function, but the underlying mechanism is unclear. Here, we examined the process of kidney cell repair in co-culture experiments with MSC and cisplatin-injured proximal tubular epithelial cells (PTEC). Exposure of PTEC to cisplatin markedly reduced cell viability at 4 days, but co-culture with MSC provided a protective effect by promoting tubular cell proliferation. This effect was mediated by insulin-like growth factor-1 (IGF-1), highly expressed by MSC as mRNA and protein, since blocking the growth factor's function with a specific antibody attenuated cell proliferation of PTEC. Confirming this, knocking down IGF-1 expression in MSC by small interfering-RNA also resulted in a significant decrease in PTEC proliferation and increased apoptosis. Furthermore, in the murine model of cisplatin-induced kidney injury, administering IGF-1 gene-silenced MSC limited their protective effect on renal function and tubular structure. These findings indicate that MSC exert beneficial effects on tubular cell repair in acute kidney injury by producing the mitogenic and pro-survival factor IGF-1.
Similar articles
-
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.Int J Mol Med. 2004 Dec;14(6):1035-41. Int J Mol Med. 2004. PMID: 15547670
-
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.Stem Cells. 2008 Aug;26(8):2075-82. doi: 10.1634/stemcells.2007-0795. Epub 2008 May 22. Stem Cells. 2008. PMID: 18499895
-
VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.Am J Physiol Renal Physiol. 2011 Jan;300(1):F207-18. doi: 10.1152/ajprenal.00073.2010. Epub 2010 Oct 13. Am J Physiol Renal Physiol. 2011. PMID: 20943766
-
Adult stem cells and renal repair.J Nephrol. 2006 Nov-Dec;19(6):706-9. J Nephrol. 2006. PMID: 17173241 Review.
-
Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.Nephrology (Carlton). 2007 Feb;12(1):44-52. doi: 10.1111/j.1440-1797.2006.00753.x. Nephrology (Carlton). 2007. PMID: 17295660 Review.
Cited by
-
Mesenchymal stem cells: from experiment to clinic.Fibrogenesis Tissue Repair. 2011 Sep 8;4:20. doi: 10.1186/1755-1536-4-20. Fibrogenesis Tissue Repair. 2011. PMID: 21902837 Free PMC article.
-
Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.J Transl Med. 2011 May 5;9:51. doi: 10.1186/1479-5876-9-51. J Transl Med. 2011. PMID: 21545725 Free PMC article.
-
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury.Am J Physiol Renal Physiol. 2008 Jul;295(1):F315-21. doi: 10.1152/ajprenal.00098.2008. Epub 2008 May 14. Am J Physiol Renal Physiol. 2008. PMID: 18480180 Free PMC article.
-
Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.Hum Gene Ther. 2008 Aug;19(8):807-19. doi: 10.1089/hum.2008.016. Hum Gene Ther. 2008. PMID: 18554097 Free PMC article.
-
Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury.Stem Cells Dev. 2009 Apr;18(3):475-85. doi: 10.1089/scd.2008.0092. Stem Cells Dev. 2009. PMID: 18564903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
